Intravitreal dexamethasone
Effect of intravitreal dexamethasone on macular edema in von Hippel Lindau disease assessed using swept source optical coherence tomography: a case report
... an intravitreal injection of ranibi- zumab and was then followed every ...an intravitreal injection of slow-release dexamethasone was considered to reduce macular edema in preparation for ...
5
Risk factors for and management of anterior chamber intravitreal dexamethasone implant migration
... A 47-year-old woman with noninfectious chronic uveitis and persistent cystoid macular edema (CME) was referred to our institution due to a dislocated IOL in the vitreous chamber in August 2010. A vitrectomy was ...
7
<p>Effect of intravitreal dexamethasone solution on the reduction of macular thickness in pseudophakic diabetic patients in a public hospital in Brazil: a randomized clinical trial</p>
... after intravitreal dexamethasone solu- tion 4 ...by dexamethasone sodium phosphate in doses ranging from 440 to 4000 μ g in rabbit ...mg/mL dexamethasone solution maximum safe dose of 200 μ g ...
9
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
... The intravitreal dexamethasone implant (Ozurdex) is effective for the treatment of diabetic macular edema, even in refractory cases that have failed to respond to previous ...
8
Adjunctive intravitreal dexamethasone in the treatment of acute endophthalmitis following cataract surgery
... receiving intravitreal antibiotics only (Shah et al ...1996). Intravitreal dexamethasone may also affect the concentration of intravitreal vancomycin, though this too is unclear, with one ...
8
Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone
... while this was not the case during the inclusion of patients in this study. Before the first injection, 8 of 12 eyes (66%) presented with an ERM, without metamorphopsia or trac- tion. The implant proved effective in ...
8
<p>The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer</p>
... Ophthalmology Associates from September 2009 to June 2018. Patient consent was not required given the retrospective nature of this study. Furthermore, the infor- mation collected had no effect on patient treatment or ...
8
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
... for dexamethasone- implant, GENEVA [7] study reported that 15% study eyes showed IOP elevation of at-least 25 mmHg peaking at day 60 and normalising by day ...
8
<p>Efficacy and Safety of Combined Vitrectomy with Intravitreal Dexamethasone Implant for Advanced Stage Epiretinal Membrane</p>
... Macular edema can be a cause of visual loss in eyes undergoing vitrectomy with ERM peeling, and its incidence evaluated by optical coherence tomography (OCT) is up to 47%. 5 In the multifactorial pathogenesis of ...
8
Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema
... To our knowledge this is the first study to examine the effect of Ozurdex intravitreal injec- tion on chromatic sensitivity. It may be of great benefit in the future to conduct a similar study to investigate ...
15
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
... that intravitreal steroid therapy could significantly improve ME and visual ...of intravitreal steroids as a pos- sible treatment could be considered due to the inflam- matory pathogenic mechanism of CRVO, ...
11
Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis
... (PRISMA) guidelines [24]. The PubMed, Embase, and Cochrane Library databases were screened up to August 2018 to complete the study. Keywords for DEX intravit- real implants included dexamethasone ...
10
Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion
... of intravitreal dexamethasone implant (Ozurdex) on macular morphology and functions in eyes with macular edema (ME) second- ary to retinal vein ...of dexamethasone implant because of the persistent ...
7
<p>Combined Intravitreal Bevacizumab And Dexamethasone In Bilateral Lupus Retinopathy</p>
... combined intravitreal bevacizumab (0.025 mL/0.625 mg) and intravitreal dexamethasone ...combined intravitreal bevacizumab ...last intravitreal injection the BCVA was 6/24 and N8 in both ...
5
The management of Irvine-Gass Syndrome in a patient using Inhaler Steroid
... and intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF), intravitreal sustained- release dexamethasone implant was ...after intravitreal dexamethasone therapy ...
5
Efficacy and safety of different doses of a slow-release corticosteroid implant for macular edema: meta-analysis of randomized controlled trials
... teroid intravitreal implants”, “intravitreal dexamethasone drug delivery system”, “steroid implants”, “dexamethasone insert”, “Ozurdex”, “fluocinolone acetonide insert”, “Retisert”, and ...
9
Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant
... pathology. Intravitreal agents, such as anti-vascular endothelial growth factors (anti-VEGF) or corticosteroids, have become more popular in recent years and are widely used for treating ...of intravitreal ...
12
<p>Dexamethasone implant in the management of diabetic macular edema from clinician’s perspective</p>
... An increase in IOP is mostly seen 45 to 60 days following intravitreal injection of DEX implant. However, a check for perfusion of the optic nerve head is advised immediately after the injection and tonometry ...
12
<p>Retinal angiographic alteration in diabetic macular edema after dexamethasone implantation: a case report</p>
... In our patient, we used the same OCTA device (Angiovue, Optovue Inc., Bayview, CA, USA) in all OCTA examina- tion, and the vessel layers was segmented manually by one ophthalmologist (HC Chen) then the VD and FAZ were ...
7
A 6-month, subject-masked, randomized controlled study to assess efficacy of dexamethasone as an adjunct to bevacizumab compared with bevacizumab alone in the treatment of patients with macular edema due to central or branch retinal vein occlusion
... the dexamethasone injection, two due to poor systemic health (one due to complications after cholecystectomy, one due to generalized malaise), and one could not be reached for follow-up ...
8